Annual report
4558.TEDINET S100R5MX
Period2022-04-01 → 2023-03-31
Filed2023-06-29
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 90
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥5.7bn | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥5.4bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥5.8bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥5.2bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥5.3bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥60m | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Operating income | ¥64m | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Ordinary income | ¥80m | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥84m | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥238m | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥87m | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥26m | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥77m | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥94m | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Net income | ¥14m | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | ¥33m | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥95m | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥10m | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥29m | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥5.2bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥5.3bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥5.2bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥4.4bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥4.6bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥2.7bn | at 2023-03-31 | Standalone | Liabilities |
| Total liabilities | ¥2.7bn | at 2022-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥2.6bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥2.6bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥2.4bn | at 2021-03-31d | Standalone | Net assets |
| Net assets / equity | ¥1.8bn | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥1.8bn | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥1.1bn | at 2023-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.4bn | at 2022-03-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥945m | at 2023-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥1.3bn | at 2022-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥1.2bn | at 2021-03-31d | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥450m | at 2020-03-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥516m | at 2019-03-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥106m | 2022-04-01 → 2023-03-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | −¥223m | 2021-04-01 → 2022-03-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥344m | 2020-04-01 → 2021-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥47m | 2019-04-01 → 2020-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥131m | 2018-04-01 → 2019-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥200m | 2022-04-01 → 2023-03-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | ¥11m | 2021-04-01 → 2022-03-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | ¥79m | 2020-04-01 → 2021-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥43m | 2019-04-01 → 2020-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥26m | 2018-04-01 → 2019-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥247m | 2022-04-01 → 2023-03-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥256m | 2021-04-01 → 2022-03-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥369m | 2020-04-01 → 2021-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥69m | 2019-04-01 → 2020-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥83m | 2018-04-01 → 2019-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥1.36 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥3.16 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥10.51 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥1.19 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥3.41 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥3.16 | 2021-04-01 → 2022-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥10.48 | 2020-04-01 → 2021-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥5 | 2022-04-01 → 2023-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥5 | 2021-04-01 → 2022-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥7 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥5 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥5 | 2018-04-01 → 2019-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥242.89 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥246.38 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥242.35 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥212.77 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥217.06 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 49.3% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 49.0% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 47.3% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.6% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 39.9% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 0.6% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 1.3% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 4.5% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 0.6% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 1.6% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 11,660,000 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 11,660,000 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 11,660,000 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 11,660,000 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 11,660,000 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 339 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 361 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 364 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 368 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 402 | at 2019-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 61
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2023-03-31 | 2 pure |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2023-03-31 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2023-03-31 | ¥2m |
| Family Doctor Medicine Sales Enterprisereportable segment | employees | at 2023-03-31 | 261 pure |
| Retail Divisionreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥193m |
| Retail Divisionreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥9m |
| Retail Divisionreportable segment | employees | at 2023-03-31 | 256 pure |
| Retail Divisionreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥4.1bn |
| Retail Divisionreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥4.1bn |
| Retail Divisionreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥44m |
| Water Operating Divisionreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥2m |
| Water Operating Divisionreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥30m |
| Water Operating Divisionreportable segment | employees | at 2023-03-31 | 34 pure |
| Water Operating Divisionreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥720m |
| Water Operating Divisionreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥688m |
| Water Operating Divisionreportable segment | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥32m |
| Water Operating Divisionreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥26m |
| Wholesaling Divisionreportable segment | employees | at 2023-03-31 | 5 pure |
| Wholesaling Divisionreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥934m |
| Wholesaling Divisionreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥934m |
| Wholesaling Divisionreportable segment | segment profit | 2022-04-01 → 2023-03-31 | −¥11m |
| —segment total | capex | 2022-04-01 → 2023-03-31 | ¥195m |
| —segment total | depreciation | 2022-04-01 → 2023-03-31 | ¥40m |
| —segment total | revenue | 2022-04-01 → 2023-03-31 | ¥5.7bn |
| —segment total | revenue external | 2022-04-01 → 2023-03-31 | ¥5.7bn |
| —segment total | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥32m |
| —segment total | segment profit | 2022-04-01 → 2023-03-31 | ¥60m |
| Total Of Reportable Segments And Otherssegment total | capex | 2022-04-01 → 2023-03-31 | ¥195m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2022-04-01 → 2023-03-31 | ¥40m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2023-03-31 | ¥5.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2023-03-31 | ¥5.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥32m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2023-03-31 | ¥60m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-04-01 → 2022-03-31 | ¥3m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-04-01 → 2022-03-31 | ¥3m |
| Retail Divisionreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥45m |
| Retail Divisionreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥39m |
| Retail Divisionreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥4.0bn |
| Retail Divisionreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥4.0bn |
| Retail Divisionreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥33m |
| Water Operating Divisionreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥1m |
| Water Operating Divisionreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥31m |
| Water Operating Divisionreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥711m |
| Water Operating Divisionreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥667m |
| Water Operating Divisionreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥44m |
| Water Operating Divisionreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥3m |
| Wholesaling Divisionreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥723m |
| Wholesaling Divisionreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥723m |
| Wholesaling Divisionreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥29m |
| —segment total | capex | 2021-04-01 → 2022-03-31 | ¥47m |
| —segment total | depreciation | 2021-04-01 → 2022-03-31 | ¥70m |
| —segment total | revenue | 2021-04-01 → 2022-03-31 | ¥5.4bn |
| —segment total | revenue external | 2021-04-01 → 2022-03-31 | ¥5.4bn |
| —segment total | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥44m |
| —segment total | segment profit | 2021-04-01 → 2022-03-31 | ¥64m |
| Total Of Reportable Segments And Otherssegment total | capex | 2021-04-01 → 2022-03-31 | ¥47m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2021-04-01 → 2022-03-31 | ¥70m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2022-03-31 | ¥5.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2022-03-31 | ¥5.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥44m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2022-03-31 | ¥64m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,162
| Item | Context | Value | Unit |
|---|---|---|---|
| Goodwill before offsetting | Prior1YearInstant_NonConsolidatedMember | 33632000 | JPY |
| Amortization of goodwill sga | CurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E03289-000FamilyDoctorMedicineSalesEnterpriseReportableSegmentsMember | 36193000 | JPY |
| Amortization of goodwill sga | CurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E03289-000WaterOperatingDivisionReportableSegmentsMember | 293000 | JPY |
| Amortization of goodwill sga | CurrentYearDuration_NonConsolidatedMember_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Amortization of goodwill sga | CurrentYearDuration_NonConsolidatedMember_UnallocatedAmountsAndEliminationMember | － | JPY |
| Amortization of goodwill sga | CurrentYearDuration_NonConsolidatedMember | 36486000 | JPY |
| Goodwill before offsetting | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E03289-000FamilyDoctorMedicineSalesEnterpriseReportableSegmentsMember | 169384000 | JPY |
| Goodwill before offsetting | CurrentYearInstant_NonConsolidatedMember_jpcrp030000-asr_E03289-000WaterOperatingDivisionReportableSegmentsMember | 1964000 | JPY |
| Goodwill before offsetting | CurrentYearInstant_NonConsolidatedMember_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Goodwill before offsetting | CurrentYearInstant_NonConsolidatedMember_UnallocatedAmountsAndEliminationMember | － | JPY |
| Goodwill before offsetting | CurrentYearInstant_NonConsolidatedMember | 171349000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)有価証券報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)東海財務局長 | |
| Filing date cover page | FilingDateInstant | 2023-06-29 | |
| Fiscal year cover page | FilingDateInstant | Original text (Japanese)第45期（自 2022年４月１日 至 2023年３月31日） | |
| Company name cover page | FilingDateInstant | Original text (Japanese)株式会社中京医薬品 | |
| Company name in english cover page | FilingDateInstant | CHUKYOIYAKUHIN CO.,LTD. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 米津 秀二 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)愛知県半田市亀崎北浦町二丁目15番地の１ | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)０５６９（２９）０２０２（代表） | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)取締役コーポレート本部長 飯田 亨 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)愛知県半田市亀崎北浦町二丁目15番地の１ | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)０５６９（２９）０２０２（代表） | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)取締役コーポレート本部長 飯田 亨 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E03289 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 45580 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)株式会社中京医薬品 | |
| Filer name in english | FilingDateInstant | CHUKYOIYAKUHIN CO.,LTD. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第三号様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | false | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | CTE | |
| Current fiscal year start date | FilingDateInstant | 2022-04-01 | |
| Current period end date | FilingDateInstant | 2023-03-31 | |
| Type of current period | FilingDateInstant | FY | |
| Current fiscal year end date | FilingDateInstant | 2023-03-31 | |
| Previous fiscal year start date | FilingDateInstant | 2021-04-01 | |
| Comparative period end date | FilingDateInstant | 2022-03-31 | |
| Previous fiscal year end date | FilingDateInstant | 2022-03-31 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 13 of 13 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |